Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancerShengjia Shi, Weihong Wen|Theranostics|2019Cited by 56
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilizationShengjia Shi, Rui Zhang|International Journal of Oncology|2023Cited by 16